Dr. Robert Babak Moghimi, MD

Dr. Moghimi practices at North Valley G.I. Consultants in Granada Hills, California.

Dr. Moghimi's NPI, 1184679664, was assigned on May 23, 2006. Dr. Moghimi graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2000. Dr. Moghimi holds California license A94790.

Dr. Moghimi's primary practice is North Valley G.I. Consultants, at 10515 N Balboa Blvd, Granada Hills, CA 91344 in Los Angeles County. The practice phone is (805) 526-6016.

Dr. Moghimi's primary practice is North Valley G.I. Consultants in Granada Hills, California. Dr. Moghimi is also affiliated with Henry Mayo Newhall Hospital. The medical group on file is North Valley GI Consultants. Dmand AI also links Dr. Moghimi to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moghimi practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Moghimi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Moghimi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Moghimi's licenses on file in 3 states: California, Virginia and Illinois.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis, cirrhosis of the liver, colonoscopy and gastrointestinal bleeding among the conditions Dr. Moghimi treats.

CMS data shows 2,980 Medicare services from Dr. Moghimi across 19 procedure codes in 2024, for 1,337 Medicare patients. Medicare paid $322,147 for them.

CMS counts 1,337 Medicare patients who saw Dr. Moghimi in 2024. The largest group is 65 to 74, with 530 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moghimi's median patient age at 64, with 53% women.

In 2024, Dr. Moghimi wrote 4,201 Medicare Part D claims for 1,432 patients. 85% of them were for generic drugs. CMS names the drug for 3,949 of them, across 40 drugs with 11 or more claims each, at $887,263 in total drug cost. In 2023, CMS named 3,598 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Moghimi for performance year 2024, reported individually. Dr. Moghimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 625 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Moghimi, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Moghimi. The most frequent topics are Iran.

Dmand AI links Dr. Moghimi to 1 clinical trial.

CMS Open Payments shows 1,112 general payments to Dr. Moghimi from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Allergan Inc. paid the most, $12,279.

Dr. Moghimi graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2000.

Dr. Moghimi is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.